Sk3 Group Stock Today
PerformanceWeakest
| Odds Of DistressSmall
|
Sk3 has about a 27 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 28th of June 2025 and ending today, the 26th of September 2025. Click here to learn more.
Category Healthcare |
SK3 Group, Inc. provides management advisory, licensing, and marketing services for medical marijuana collectives in California. The company was founded in 2000 and is headquartered in Los Angeles, California. Sk3 is traded on OTC Exchange in the United States. More on Sk3 Group
Sk3 Group cannot be verified against its exchange. Apparently, Sk3 is not available for investing at the moment. Please verify the symbol is currently traded on OTCCE Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
RefreshSk3 Stock Highlights
| Chief President | Artemus Mayor | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Drug Manufacturers - Specialty & Generic, Healthcare, Health Care Providers & Services, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sk3 Group (SKTO) is traded on OTCCE Exchange in USA and employs 15 people. The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.52 M. Sk3 Group conducts business under Healthcare sector and is part of Health Care Providers & Services industry.
Sk3 Group currently holds about 284 in cash with (594.4 K) of positive cash flow from operations.
Check Sk3 Probability Of Bankruptcy
Sk3 Stock Against Markets
Try Other Suggestions
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sk3 Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Drug Manufacturers - Specialty & Generic space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sk3. If investors know Sk3 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sk3 listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Sk3 Group is measured differently than its book value, which is the value of Sk3 that is recorded on the company's balance sheet. Investors also form their own opinion of Sk3's value that differs from its market value or its book value, called intrinsic value, which is Sk3's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sk3's market value can be influenced by many factors that don't directly affect Sk3's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sk3's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sk3 is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sk3's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.